An anti-inflammatory or immunosuppressive treatment for some diseases including causes due to hematology, allergies, arthritis, cancer and autoimmune.
Adult: initial dosage from 2 – 60 mg daily in 4 divided doses.
Children: based on the severity of the disease and the response, after a satisfactory response is obtained, dosage should be decreased in small decrements to the lowest level that maintains adequate clinical response.
When long-term use: consider an alternate day dosage regimen, then withdrawn gradually.
Contact dermatitis: 24 mg (6 tablets of 4 mg) for the first day, then tapered by 4 mg daily until 21 tablets have been administered for 6 days (6, 5, 4, 3, 2, 1 is the amount of tablets administered from the first day to the sixth day respectively).
- Children < 4 years old (more than 3 exacerbations per year) and children 5 – 11 years old (at least 2 exacerbations per year): 1 – 2 mg/kg/day (maximum 60 mg daily) may be added to existing asthma therapy.
- Adults and adolescents (at least 2 exacerbations per year): 40-60 mg daily as a single dose or in 2 divided doses, may be added to low-to-high maintenance dosages in the inhaled corticosteroid and a long-acting inhaled b2-agonist bronchodilator, a short course (usually 3 – 10 days) of oral corticosteroid therapy should be continued until the patient achieves a peak expiratory flow (PEF) of 80% of his or her personal best and until symptoms resolve. Once asthma is well controlled, repeated attempts should be made to reduce the oral corticosteroid dosage.
Stadsone 4 is orally administered.